Edwards Lifesciences (EW) Assets Average (2010 - 2026)

Edwards Lifesciences' Assets Average history runs 17 years deep, the most recent figure standing at $13.5 billion for Q1 2026.

• In Q1 2026, Assets Average rose 3.61% year-over-year to $13.5 billion; the TTM figure through Mar 2026 stood at $13.5 billion (up 3.61% YoY), while the FY2025 annual figure was $13.4 billion, up 19.33% from the prior year.
• Assets Average was $13.5 billion for Q1 2026 at Edwards Lifesciences, roughly flat from $13.5 billion in the prior quarter.
• In the past five years, Assets Average ranged from a high of $13.5 billion in Q1 2026 to a low of $8.4 billion in Q2 2022.
• Historically, Assets Average has averaged $10.6 billion across 5 years, with a median of $9.5 billion in 2024.
• The sharpest annual moves came in 2023 and 2024: Assets Average grew 0.13% in 2023, then soared 38.93% in 2024.
• A 5-year view of Assets Average shows it stood at $8.5 billion in 2022, then advanced by 10.65% to $9.4 billion in 2023, then jumped by 38.93% to $13.0 billion in 2024, then advanced by 3.62% to $13.5 billion in 2025, then advanced by 0.18% to $13.5 billion in 2026.
• The last three Assets Average figures came in at $13.5 billion (Q1 2026), $13.5 billion (Q4 2025), and $13.4 billion (Q3 2025), per Business Quant data.